Ledger.Open graph →
SEC Form D · filed March 26, 2019

Alessa Therapeutics, Inc

Offering
$3.5M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Doug Crawford · San Francisco, CADirectorKate D. Jones · Los Angeles, CADirectorMartin Hale, Jr · New York, NYDirectorRobert Reali · Goleta, CADirectorPamela Munster · San Francisco, CADirectorJeffrey M. Stroll · Los Angeles, CADirectorPeter Parker · San Francisco, CADirectorDavid Paden · Goleta, CADirectorRonald C. Brandenburg · Oakland Park, FLExec · DirectorMichael M. Ricci · Goleta, CADirectorJohn Maroney · San Francisco, CAExec · DirectorTerrance P. Gallagher · Milwaukee, WIExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗